Abstract
Systemic lupus erythematosus (SLE) is a complex autoimmune disease in which genetic factors strongly influence susceptibility. Cytokines such as the interferon-gamma (IFNG) gene play a key role in controlling the immunity and inflammation, and therefore their polymorphisms may affect these genes’ expression levels among individuals. We investigated the frequency of IFNG gene intron (+874) polymorphism, previously reported to be associated with IFNG production, in SLE patients compared to a control group. This population-based case–control study includes 154 SLE patients and 154 healthy control subjects with similar ethnic backgrounds. The genotyping was determined by polymerase chain reaction sequence-specific primer method and using the Chi-squared test for analyzing the association between this single-nucleotide polymorphism and SLE. The allele frequencies of the IFNG (+874) gene polymorphism were not significantly different between SLE patients and control subjects (72.7 vs 77%). However, there was a significant association between A dominance model of inheritance with arthritis (odds ratio = 7.64, 95% confidence interval = 1.56–41.64, P = 0.006, P c = 0.03). The result suggested that the +874 intron polymorphism of IFNG can be used as the marker for SLE susceptibility with arthritis in the Thai population.
Similar content being viewed by others
References
Baccala R, Kono DH, Theofilopoulos AN (2005) Interferons as pathogenic effectors in autoimmunity. Immunol Rev 204:9–26
Csiszar A, Nagy G, Gergely P et al (2000) Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 122:464–470
Lit LC, Wong CK, Tam LS et al (2006) Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann Rheum Dis 65:209–215
Gomez D, Correa PA, Gomez LM et al (2004) Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective? Semin Arthritis Rheum 33:404–413
al-Janadi M, al-Balla S, al-Dalaan A et al (1993) Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 13:58–67
Adam C, Thoua Y, Ronco P et al (1980) The effect of exogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W) F1 mice. Clin Exp Immunol 40:373–382
Amital H, Levi Y, Blank M et al (1998) Immunomodulation of murine experimental SLE-like disease by interferon-gamma. Lupus 7:445–454
Jacob CO, Meide PH, McDevitt HO (1987) In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J Exp Med 166:798–803
Akahoshi M, Nakashima H, Tanaka Y et al (1999) Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum 42:1644–1648
Takahashi S, Fossati L, Iwamoto M et al (1996) Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest 97:1597–604
Funauchi M, Ikoma S, Enomoto H et al (1998) Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus. Scand J Rheumatol 27:219–224
Min DJ, Cho ML, Cho CS et al (2001) Decreased production of interleukin-12 and interferon-gamma is associated with renal involvement in systemic lupus erythematosus. Scand J Rheumatol 30:159–163
Jones BM, Liu T, Wong RW (1999) Reduced in vitro production of interferon-gamma, interleukin-4 and interleukin-12 and increased production of interleukin-6, interleukin-10 and tumour necrosis factor-alpha in systemic lupus erythematosus. Weak correlations of cytokine production with disease activity. Autoimmunity 31:117–124
Horwitz DA, Gray JD, Behrendsen SC et al (1998) Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum 41:838–844
Nicoletti F, Di Marco R, Zaccone P et al (2000) Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr/lpr mice. Eur J Immunol 30:438–447
Pravica V, Asderakis A, Perrey C et al (1999) In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 26(1):1–3
Pravica V, Perrey C, Stevens A et al (2000) A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 61(9):863–866
Lee JY, Goldman D, Piliero LM et al (2004) Interferon-gamma polymorphisms in systemic lupus erythematosus. Genes Immun 2(5):254–257
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215
Awad M, Pravica V, Perrey C et al (1999) CA repeat allele polymorphism in the first intron of the human interferon-gamma gene is associated with lung allograft fibrosis. Hum Immunol 60(4):343–346
Dean AG, Dean JA, Burton AH et al (1991) Epi Info: a general-purpose microcomputer program for public health information systems. Am J Prev Med 7(3):178–182
Nakashima H, Inoue H, Akahoshi M et al (1999) The combination of polymorphisms within interferon-gamma receptor 1 and receptor 2 associated with the risk of systemic lupus erythematosus. FEBS Lett 453(1–2):187–190
Tanaka Y, Nakashima H, Hisano C et al (1999) Association of the interferon-gamma receptor variant (Val14Met) with systemic lupus erythematosus. Immunogenetics 49(4):266–271
Acknowledgments
This study was supported by the Human Genetics grant from National Center for Genetic Engineering and Biotechnology (BIOTEC), Thailand, Ministry of University Affairs (MUA)–CU Thesis Grant 2002, and Lupus Research Unit, Chulalongkorn University. The authors wish to thank all the patients for their cooperation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tangwattanachuleeporn, M., Sodsai, P., Avihingsanon, Y. et al. Association of interferon-gamma gene polymorphism (+874A) with arthritis manifestation in SLE. Clin Rheumatol 26, 1921–1924 (2007). https://doi.org/10.1007/s10067-007-0699-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-007-0699-6